Primolut-Nor | Australian Register of Therapeutic Goods | Australia | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Primolut-Nor
Australia

PharmaCompass Sponsored Ads

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Norethisterone Acetate

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Contact Supplier

xyz-pharma-m-2025-06-09

Primolut-Nor

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 12 USDMF, 4 CEP/COS, 2 JDMF, 1 EU WC, 5 NDC API, 12 Listed Suppliers, $ API Reference Price

24 API Suppliers
12 USDMF
4 CEP/COS
2 JDMF
1 EU WC
5 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

FINISHED DOSAGE FORMULATIONS

184 FDF Dossiers, 119 FDA Orange Book, 39 Europe, 7 Canada, 12 Australia, 7 Listed Dossiers

184 FDF Dossiers
119 FDA Orange Book
39 Europe
7 Canada
12 Australia
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-28 - 0.02MG;1MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.03MG;1.5MG, TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG, INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG, CAPSULE;ORAL - 0.02MG;1MG, TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR, FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR, TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1MG;0.5MG, TABLET;ORAL - 0.0025MG;0.5MG, TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

TABLET;ORAL-28 - 0.02MG;1MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.03MG;1.5MG
TABLET;ORAL-21 - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL-21 - 0.02MG,0.03MG,0.035MG;1MG,1MG,1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 11.25MG/VIAL,N/A;N/A,5MG
INJECTABLE, TABLET;INTRAMUSCULAR, ORAL - 3.75MG/VIAL,N/A;N/A,5MG
CAPSULE;ORAL - 0.02MG;1MG
TABLET, CHEWABLE, TABLET;ORAL - 0.01MG,0.01MG,N/A;1MG,N/A,N/A
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.14MG/24HR
FILM, EXTENDED RELEASE;TRANSDERMAL - 0.05MG/24HR;0.25MG/24HR
TABLET;ORAL - 0.5MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 1MG;0.5MG
TABLET;ORAL - 0.0025MG;0.5MG
TABLET;ORAL - 0.005MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.02MG;1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 0.01MG,0.01MG;1MG,N/A

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 5 SPI Pharma, 6 DKSH, 6 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 4 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 19 BASF, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 11 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 38 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 54 Coating Systems & Additives, 31 Disintegrants & Superdisintegrants, 29 Direct Compression, 28 Controlled & Modified Release, 27 Granulation, 25 Solubilizers, 22 Thickeners and Stabilizers, 20 Lubricants & Glidants, 19 Co-Processed Excipients, 16 Taste Masking, 14 Parenteral, 14 Film Formers & Plasticizers, 10 Emulsifying Agents, 9 Topical, 8 Rheology Modifiers, 8 API Stability Enhancers, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 4 Vegetarian Capsules

78 Fillers, Diluents & Binders
54 Coating Systems & Additives
31 Disintegrants & Superdisintegrants
29 Direct Compression
28 Controlled & Modified Release
27 Granulation
25 Solubilizers
22 Thickeners and Stabilizers
20 Lubricants & Glidants
19 Co-Processed Excipients
16 Taste Masking
14 Parenteral
14 Film Formers & Plasticizers
10 Emulsifying Agents
9 Topical
8 Rheology Modifiers
8 API Stability Enhancers
6 Chewable & Orodispersible Aids
5 Coloring Agents
5 Empty Capsules
5 Surfactant & Foaming Agents
4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

1 Data Compilation #PharmaFlow
47 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 40 Regulatory FDF Prices, 9 Annual Reports

2 US Medicaid Prescriptions
40 Regulatory FDF Prices
9 Annual Reports

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

9 US Patents, 4 US Exclusivities

9 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 Others

2 EDQM
1 USP
1 Others

$ API Ref.Price (USD/KG) : 3,359 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

12 All

01 4Medsurge Healthcare

02 8Sandoz B2B

filter Active Ingredients Reset all filters

12 All

01 12Estradiol; Norethisterone Acetate

filter Dosage Form Reset all filters

12 All

01 4Sachet

02 8Transdermal Patch

filter Brand Name Reset all filters

12 All

01 2ESTALIS 140/50 (Canada)

02 2ESTALIS 250/50 (Canada)

03 2Estalis continuous 50/140

04 2Estalis continuous 50/250

05 2Estalis sequi 50/140

06 2Estalis sequi 50/250

Coral Drugs Norethisterone Acetate

List of Suppliers

Product Main Page

01

Medsurge Healthcare

DIA 2025

Not Confirmed

Medsurge Healthcare

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : ESTALIS 140/50 (Canada)

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Medsurge Healthcare

DIA 2025

Not Confirmed

Medsurge Healthcare

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : ESTALIS 140/50 (Canada)

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Medsurge Healthcare

DIA 2025

Not Confirmed

Medsurge Healthcare

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : ESTALIS 250/50 (Canada)

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Medsurge Healthcare

DIA 2025

Not Confirmed

Medsurge Healthcare

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : ESTALIS 250/50 (Canada)

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Sandoz B2B

DIA 2025

Not Confirmed

Sandoz B2B

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : Estalis continuous 50/140

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Product Web Link

Digital Content

06

Sandoz B2B

DIA 2025

Not Confirmed

Sandoz B2B

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : Estalis sequi 50/140

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Product Web Link

Digital Content

07

Sandoz B2B

DIA 2025

Not Confirmed

Sandoz B2B

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : Estalis sequi 50/250

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Product Web Link

Digital Content

08

Sandoz B2B

DIA 2025

Not Confirmed

Sandoz B2B

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : Estalis continuous 50/250

Dosage Form : Transdermal Patch

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Product Web Link

Digital Content

09

Sandoz B2B

DIA 2025

Not Confirmed

Sandoz B2B

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : Estalis sequi 50/140

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Product Web Link

Digital Content

10

Sandoz B2B

DIA 2025

Not Confirmed

Sandoz B2B

DIA 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Australia

Estradiol; Norethisterone Acetate

Brand Name : Estalis sequi 50/250

Dosage Form : Sachet

Dosage Strength : 50MCG

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

Product Web Link

Digital Content

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!